Pomalidomide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT01212952 · COMPLETED
Trial details
- NCT number
- NCT01212952
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2017-08-15
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.